BALA CYNWYD, Pa., July 28, 2009 (GLOBE NEWSWIRE) -- Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Varian, Inc. ("Varian" or the "Company") (Nasdaq:VARI) relating to the proposed acquisition by Agilent Technologies ("Agilent") (NYSE:A). Agilent has agreed to acquire Varian in an all-cash deal valued at approximately $1.5 billion.
Under the proposed agreement, Varian shareholders will receive $52.00 for every share of Varian common stock they own. The investigation concerns possible breaches of fiduciary duty and other violations of state law related to the Varian board's approval of the proposed merger. Among other items, the merger agreement restricts Varian from soliciting superior bids from other potential purchasers.
If you own shares of Varian and wish to discuss the legal ramifications of the proposed acquisition by Agilent, or have any questions, you may e-mail or call the law office of Brodsky & Smith, LLC who will, without obligation or cost to you, attempt to answer your questions. You may contact Jason L. Brodsky, Esquire or Marc L. Ackerman, Esquire at Brodsky & Smith, LLC, Two Bala Plaza, Suite 602, Bala Cynwyd, PA 19004, by e-mail at clients@brodsky-smith.com, or by calling toll free 877-LEGAL-90.